Back to search
FDAFDA · Food and drugs·Recall number D-0186-2025

Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10

Published January 15, 2025 · Recall initiated: December 27, 2024

Summary

FDA records drug Class II recall D-0186-2025, published January 15, 2025 and initiated December 27, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 17,300 10-mL vials; Lot: Batch # 1PR24010, Expiry: 02/28/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

What to do

Voluntary: Firm initiated · Letter

Get an email if PROGESTERONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PROGESTERONE
Manufacturer
Eugia US LLC
Distributor
Distributed Nationwide in the USA.
Lot
Batch # 1PR24010, Expiry: 02/28/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10 recalled?

Yes. FDA published recall D-0186-2025 on January 15, 2025. Reported hazard: Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PROGESTERONE.